BIST10013.290,41▼ -1.56%Bank Deposits Surge to Record Levels: Implications for the BIST 100USD/TRY47.5989▲ 0.20%Q2 GDP Up 1.5%: Uncovering the Hidden Engines Driving US GrowthEUR/TRY54.6353▲ 0.30%Robinhood's Best Quarter Signals Crypto Market ReboundBTC/USD$64,773.77▲ 0.87%US Q2 Growth Falls Short of Expectations: Government Spending ConstraintsGOLD6.220,23▲ 0.15%Girişim Electric's 294 Million TL Win: Strengthening Its Strategic Position in Energy SectorBRENT$89.75▼ -1.09%Definium Therapeutics (DFTX) Redefines Depression & Anxiety Treatment Middle East Crisis: UK Interest Rates Hold Steady Despite Inflation ConcernsBIST10013.290,41▼ -1.56%Bank Deposits Surge to Record Levels: Implications for the BIST 100USD/TRY47.5989▲ 0.20%Q2 GDP Up 1.5%: Uncovering the Hidden Engines Driving US GrowthEUR/TRY54.6353▲ 0.30%Robinhood's Best Quarter Signals Crypto Market ReboundBTC/USD$64,773.77▲ 0.87%US Q2 Growth Falls Short of Expectations: Government Spending ConstraintsGOLD6.220,23▲ 0.15%Girişim Electric's 294 Million TL Win: Strengthening Its Strategic Position in Energy SectorBRENT$89.75▼ -1.09%Definium Therapeutics (DFTX) Redefines Depression & Anxiety Treatment Middle East Crisis: UK Interest Rates Hold Steady Despite Inflation Concerns

Global MarketsJuly 30, 2026 at 04:37 PM

Definium Therapeutics (DFTX) Redefines Depression & Anxiety Treatment

724FinanceKaptan Rıza Deniz

Definium Therapeutics (DFTX) Redefines Depression & Anxiety Treatment

Meridian Small Cap Growth Fund's Q2 2026 investor letter highlighted Definium Therapeutics (NASDAQ:DFTX), a biopharmaceutical company developing a single-dose LSD-based therapy for major depressive disorder and generalized anxiety disorder. The company reported positive topline results from its pivotal Phase 3 study, exceeding investor-set efficacy benchmarks with durable treatment effects and high remission rates versus placebo. This success significantly de-risked the program and set the stage for the first generalized anxiety disorder readout. DFTX, with a $5.6 billion market cap, surged 363.81% over 52 weeks. Meridian Fund emphasized its potential to lead in large, underserved mental health markets and its pipeline approaching pivotal readouts. How will markets react to this breakthrough?